We present a descriptive analysis utilizing pharmacy claims from a managed care population to quantify adherence, persistence, and switching patterns for patients initiating dabigatran.
Ann S. M. Harada, PhD, MPH
Advertisement
Articles by Ann S. M. Harada, PhD, MPH
Improving Patient Self-Management of Multiple Sclerosis Through a Disease Therapy Management Program
This study evaluated the effect of a multiple sclerosis disease therapy management program on medication adherence, therapy persistence, relapses, work productivity, and quality of life.
Advertisement
Latest Updated Articles
- Improving Patient Self-Management of Multiple Sclerosis Through a Disease Therapy Management Program
Published: February 5th 2010 | Updated:
- Adherence, Persistence, and Switching Patterns of Dabigatran Etexilate
Published: September 16th 2013 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
2025 Nobel Prize in Medicine Honors Discoveries Behind Regulatory T Cells
2
Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms
3
FDA Expands Roflumilast Use for Atopic Dermatitis to Children Aged 2 to 5 Years
4
Mediterranean Diet Improves Psoriasis Severity, Study Finds
5
